CoChat

A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease

Open access

The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.

Abstract

The presence of cirrhosis in nonalcoholic-fatty-liver-disease (NAFLD) is the most important predictor of liver-related mortality. Limited data exist concerning the diagnostic accuracy of gut-microbiome-derived signatures for detecting NAFLD-cirrhosis. Here we report 16S gut-microbiome compositions of 203 uniquely well-characterized participants from a prospective twin and family cohort, including 98 probands encompassing the entire spectrum of NAFLD and 105 of their first-degree relatives, assessed by advanced magnetic-resonance-imaging. We show strong familial correlation of gut-microbiome profiles, driven by shared housing. We report a panel of 30 features, including 27 bacterial features with discriminatory ability to detect NAFLD-cirrhosis using a Random Forest classifier model. In a derivation cohort of probands, the model has a robust diagnostic accuracy (AUROC of 0.92) for detecting NAFLD-cirrhosis, confirmed in a validation cohort of relatives of proband with NAFLD-cirrhosis (AUROC of 0.87). This study provides evidence for a fecal-microbiome-derived signature to detect NAFLD-cirrhosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-019-09455-9

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Familial association and shared microbiome among relatives is driven by shared housing. Distribution of spearman correlation coefficients between relatives in purple (n = 86) and unrelated pairs in orange (n = 18232) in the familial cohort, plotted for each phyla (a) and 16S tag sequences (b). The box plots show the quartiles and whiskers show the rest of the distribution (1.5 inter-quartile range) and the center line corresponds to the median. This analysis was done after filtering rare 16S sequences to avoid spurious correlations due to sparsity (total abundance <10E-6 across all samples in each disease group). The correlation among related individuals was significantly higher at both phylum (p = 0.023) and 16S tag sequences (p = 2.4E-41) levels. Similar plot showing the distribution of unweighted UniFrac distances between related in purple and unrelated pairs stratified by disease status (c). The beta-diversity was significantly lower among related individuals (p = 3.22E-05), non-NAFLD controls and relative in blue (n = 38 pairs) (p = 0.0011) and probands with NAFLD without AF and relatives in yellow (n = 15) (p = 0.0156) when compared to the same among unrelated pairs in orange, while the difference between NALFD-cirrhosis patients and relatives in pink (n = 33) and unrelated pairs in orange was not statistically significant (p > 0.1). When stratified by shared housing (d), beta-diversity was significantly lower among related individuals sharing a house in purple (n = 35 pairs) (p = 0.0455). Additionally, related individuals not sharing a house in white (n = 51 pairs) had significantly lower beta-diversity compared to unrelated pairs in orange (p = 0.028). All p value were determined by two-sided Kruskal-Wallis test. *p value < 0.05. Source data are provided as a Source Data file
Fig. 1 Familial association and shared microbiome among relatives is driven by shared housing. Distribution of spearman correlation coefficients between relatives in purple (n = 86) and unrelated pairs in orange (n = 18232) in the familial cohort, plotted for each phyla (a) and 16S tag sequences (b). The box plots show the quartiles and whiskers show the rest of the distribution (1.5 inter-quartile range) and the center line corresponds to the median. This analysis was done after filtering rare 16S sequences to avoid spurious correlations due to sparsity (total abundance <10E-6 across all samples in each disease group). The correlation among related individuals was significantly higher at both phylum (p = 0.023) and 16S tag sequences (p = 2.4E-41) levels. Similar plot showing the distribution of unweighted UniFrac distances between related in purple and unrelated pairs stratified by disease status (c). The beta-diversity was significantly lower among related individuals (p = 3.22E-05), non-NAFLD controls and relative in blue (n = 38 pairs) (p = 0.0011) and probands with NAFLD without AF and relatives in yellow (n = 15) (p = 0.0156) when compared to the same among unrelated pairs in orange, while the difference between NALFD-cirrhosis patients and relatives in pink (n = 33) and unrelated pairs in orange was not statistically significant (p > 0.1). When stratified by shared housing (d), beta-diversity was significantly lower among related individuals sharing a house in purple (n = 35 pairs) (p = 0.0455). Additionally, related individuals not sharing a house in white (n = 51 pairs) had significantly lower beta-diversity compared to unrelated pairs in orange (p = 0.028). All p value were determined by two-sided Kruskal-Wallis test. *p value < 0.05. Source data are provided as a Source Data fileCC BY · PubMed Central
Fig. 2 Gut microbiome alteration in NAFLD-cirrhosis. Comparison between non-NAFLD controls in blue (n = 51), NAFLD without advanced fibrosis in yellow (n = 17), and NAFLD-cirrhosis probands in pink (n = 25) with respect to a alpha-diversity using Faith’s Phylogenetic Diversity. Non-NAFLD controls have significantly higher alpha-diversity compared to probands with NAFLD without AF in yellow (p = 0.0163) and NAFLD-cirrhosis in pink (p = 0.0020). b Similar plot for beta-diversity using unweighted UniFrac distance metric. The beta-diversity among probands with NAFLD without AF in yellow was significantly lower than that among non-NAFLD controls in blue (p = 1.14E-18) and probands with NAFLD-cirrhosis in pink (p = 3.32E-15). The box plots show the quartiles and whiskers show the rest of the distribution (1.5 inter-quartile range) the center liner corresponds to the median. c Gut microbiome composition of non-NAFLD controls, NAFLD without AF and NALFD-cirrhosis probands shows differences at bacterial genus level. All p value were determined by two-sided Kruskal-Wallis test. *p value < 0.05. Source data are provided as a Source Data file
Fig. 2 Gut microbiome alteration in NAFLD-cirrhosis. Comparison between non-NAFLD controls in blue (n = 51), NAFLD without advanced fibrosis in yellow (n = 17), and NAFLD-cirrhosis probands in pink (n = 25) with respect to a alpha-diversity using Faith’s Phylogenetic Diversity. Non-NAFLD controls have significantly higher alpha-diversity compared to probands with NAFLD without AF in yellow (p = 0.0163) and NAFLD-cirrhosis in pink (p = 0.0020). b Similar plot for beta-diversity using unweighted UniFrac distance metric. The beta-diversity among probands with NAFLD without AF in yellow was significantly lower than that among non-NAFLD controls in blue (p = 1.14E-18) and probands with NAFLD-cirrhosis in pink (p = 3.32E-15). The box plots show the quartiles and whiskers show the rest of the distribution (1.5 inter-quartile range) the center liner corresponds to the median. c Gut microbiome composition of non-NAFLD controls, NAFLD without AF and NALFD-cirrhosis probands shows differences at bacterial genus level. All p value were determined by two-sided Kruskal-Wallis test. *p value < 0.05. Source data are provided as a Source Data fileCC BY · PubMed Central
Fig. 3 Relative abundance of predictive microbial features for the prediction of NAFLD-cirrhosis. The bacterial features most predictive of NAFLD-cirrhosis (n = 25) versus non-NAFLD controls (n = 51) sorted by decreasing importance score in Random Forest classification model. Features increased (a) and decreased (b) in NAFLD-cirrhosis probands are shown. Relative abundance is plotted for each subject group in the cohort (NAFLD-cirrhosis in pink (n = 25), NAFLD without advanced fibrosis in yellow (n = 17) and non-NAFLD controls in blue (n = 51)). The feature table is normalized to a total abundance of 1 per sample and relative abundances are plotted on a log10 scale. Each bacterial feature is a unique 16S tag sequence labeled to the highest possible taxonomic rank assigned using QIIME. The box plots show the quartiles and whiskers show the rest of the distribution (1.5 inter-quartile range). The notches show 95% confidence interval. Features that are differentially abundant in addition to being important predictors are marked by asterisk. Single asterisk (*) represents significant difference between non-NAFLD controls and NAFLD-cirrhosis probands p value < 0.05; Double asterisk (**) represents the same between NAFLD without advanced fibrosis and NAFLD cirrhosis probands p value < 0.05. Differential abundance was tested using permutation-based, ranked mean test, comparing mean difference between the two groups63. FDR (<0.1) was controlled using DS-FDR method64. Source data are provided as a Source Data file
Fig. 3 Relative abundance of predictive microbial features for the prediction of NAFLD-cirrhosis. The bacterial features most predictive of NAFLD-cirrhosis (n = 25) versus non-NAFLD controls (n = 51) sorted by decreasing importance score in Random Forest classification model. Features increased (a) and decreased (b) in NAFLD-cirrhosis probands are shown. Relative abundance is plotted for each subject group in the cohort (NAFLD-cirrhosis in pink (n = 25), NAFLD without advanced fibrosis in yellow (n = 17) and non-NAFLD controls in blue (n = 51)). The feature table is normalized to a total abundance of 1 per sample and relative abundances are plotted on a log10 scale. Each bacterial feature is a unique 16S tag sequence labeled to the highest possible taxonomic rank assigned using QIIME. The box plots show the quartiles and whiskers show the rest of the distribution (1.5 inter-quartile range). The notches show 95% confidence interval. Features that are differentially abundant in addition to being important predictors are marked by asterisk. Single asterisk (*) represents significant difference between non-NAFLD controls and NAFLD-cirrhosis probands p value < 0.05; Double asterisk (**) represents the same between NAFLD without advanced fibrosis and NAFLD cirrhosis probands p value < 0.05. Differential abundance was tested using permutation-based, ranked mean test, comparing mean difference between the two groups63. FDR (<0.1) was controlled using DS-FDR method64. Source data are provided as a Source Data fileCC BY · PubMed Central
Fig. 4 High diagnostic accuracy of a gut-microbiome signature for the detection of NAFLD-cirrhosis. Receiver operating characteristic (ROC) curves evaluating ability to predict advanced Fibrosis using Random Forest classification. Each curve represents the sensitivity and specificity to distinguish subjects with NAFLD-cirrhosis (1, brown line) from non-NALFD controls (0, green line). a Mean ROC curve from cross-validation within training data comprised of NAFLD-cirrhosis probands (n = 24) and non-NAFLD controls (n = 47). Cross-validation was performed by iteratively (10 times) training the Random Forest model with 70:30 train/test split on this training data. b ROC curve representing diagnostic accuracy of Random Forest classification model tested on first-degree relatives of NAFLD-cirrhosis probands (n = 32). The negative predictive value (NPV) of the model was 91.6% and the positive predictive value was 62.5%. Source data are provided as a Source Data file
Fig. 4 High diagnostic accuracy of a gut-microbiome signature for the detection of NAFLD-cirrhosis. Receiver operating characteristic (ROC) curves evaluating ability to predict advanced Fibrosis using Random Forest classification. Each curve represents the sensitivity and specificity to distinguish subjects with NAFLD-cirrhosis (1, brown line) from non-NALFD controls (0, green line). a Mean ROC curve from cross-validation within training data comprised of NAFLD-cirrhosis probands (n = 24) and non-NAFLD controls (n = 47). Cross-validation was performed by iteratively (10 times) training the Random Forest model with 70:30 train/test split on this training data. b ROC curve representing diagnostic accuracy of Random Forest classification model tested on first-degree relatives of NAFLD-cirrhosis probands (n = 32). The negative predictive value (NPV) of the model was 91.6% and the positive predictive value was 62.5%. Source data are provided as a Source Data fileCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 62 references

Research works printed but not linked: 1

  1. Classification, LiawA. and Regression by randomForest. R. News 2, 18–22 (2002).

Cited by

See all 348

Metadata

Authors
Caussy, C., Tripathi, A., Humphrey, G., Bassirian, S., Singh, S., Faulkner, C., Bettencourt, R., Rizo, E., Richards, L., Xu, Z. Z., Downes, M. R., Evans, R. M., Brenner, D. A., Sirlin, C. B., Knight, R., & Loomba, R.
Affiliations
  • Lyon 1 Université (FR)
  • University of California San Diego (US)
  • Salk Institute for Biological Studies (US)
Corresponding author
Loomba, Rohit
Venue
Nature Communications
Published
2019-03-29
Volume
10
Issue
1
Pages
1406-1406
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2933882285
Cited by
338
References
62
Citations by year
2026: 31 · 2025: 40 · 2024: 44 · 2023: 37 · 2022: 62 · 2021: 65 · 2020: 45 · 2019: 14
FWCI
15.38
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • John A. Hartford Foundation (K23-DK090303)
  • Hartford Foundation for Public Giving
  • American Gastroenterological Association (K23DK090303)
  • Georgia Clinical and Translational Science Alliance (UL1TR001442)
  • National Institutes of Health (UL1TR001442, UL1TR001442 of CTSA, Grant UL1TR001442, Grant UL1TR001442 of CTSA)
  • National Heart, Lung, and Blood Institute (R01HL105278, P01HL088093)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R37DK057978, K23DK090303)
  • National Institute of Environmental Health Sciences (P42ES010337)
  • National Center for Advancing Translational Sciences
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
Keywords
non-alcoholic fatty liver disease, liver cirrhosis, gut microbiota, diagnostic biomarkers, familial correlation, shared housing, random forest, liver-related mortality
MeSH terms
Gastrointestinal Microbiome, Bacteria, Family, Feces, Female, Humans, Liver Cirrhosis, Male, ROC Curve, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease. https://app.cochat.ai/papers/10.1038/s41467-019-09455-9
The paper
Caussy, C., Tripathi, A., Humphrey, G., Bassirian, S., Singh, S., Faulkner, C., Bettencourt, R., Rizo, E., Richards, L., Xu, Z. Z., Downes, M. R., Evans, R. M., Brenner, D. A., Sirlin, C. B., Knight, R., & Loomba, R. (2019). A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease. Nature Communications. https://doi.org/10.1038/s41467-019-09455-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.